LOG IN
|
Services
|
Contact
|
Custom Research
Search
Advanced search
Main
Healthcare, Pharmaceuticals & Biotechnology
Biotechnology
Technology Meets Drug Discovery: The Bioinformatics Revolution
Publications
Business, Finance & Insurance
(35706)
Consumer Goods & Retail
(127031)
Databases & Statistics
(27)
Education & Consulting
(0)
Industry
(87698)
Healthcare, Pharmaceuticals & Biotechnology
(58540)
Biotechnology
(9100)
Pharmaceuticals
(30490)
Healthcare and drugs
(18950)
Services
(0)
Government and Public Sector
(553)
Technologies & Electronics
(91477)
Company reports
(70860)
Country reports
(2187)
(Currently 512486 Items)
Partners
Biotechnology / REPORT INFORMATION
Technology Meets Drug Discovery: The Bioinformatics Revolution
Date
Jan, 2001
Pages
0
Price / format
€2097 / Hard Copy
€2033 / Electronic
€2033 / Site License
€2 033
Report Information
|
Custom-Tailored Research
|
Product Trade Lead
Abstract:
This market brief looks at the evolving computer and IT systems that are being applied to drug discovery to speed time to market. How can you benefit from this report? * Assess the impact of IT developments on the drug discovery process * Identify the strategic opportunities created by bioinformatics * Develop strategies to leverage the power of bioinformatics
Table of contents:
DATAMONITOR HEALTHCARE
ACTION POINTS
Outline of the brief
Three key things you need to know about IT and drug discovery
Assess the potential of peer-to-peer technology. It can prove beneficial in terms of both efficiency and cost. For companies performing novel bioscientific research, it can also provide a means to generate public interest.
Form associations, either practical or purely advisory, with IT companies demonstrating a life science focus. Realizing the competitive advantage offered by emerging technologies requires involvement with the industry.
Ensure that adverse event tracking systems evolve in parallel with drug discovery methodologies. As laboratory analyses are replaced by data manipulation, public and professional concern over drug safety will increase.
TECHNOLOGY MEETS DRUG DISCOVERY
Introduction
The innovation race
Peer-to-peer computing
Pharmacovigiliance software
MEMS technology
Big Tech and Biotech
Compaq
IBM
Sun Microsystems
Conclusion
THE FUTURE DECODED
The Desktop laboratory?experimenting with virtual drug targets
Increasing pressure from investors-for both IT and bioscience companies
The emergence of the data providers?a growing industry
APPENDIX
References
SPP writing team
Order this report
Company name:
Contact person:
Phone/fax:
Email:
Comments:
Product Trade Lead
0 leads found
Add New Buy/Sell Lead
Type:
Buy
Sell
Offer:
Contacts:
Capture:
© 2007-2010 MarketReportFinder.com